[HTML][HTML] Nanoparticle-mediated brain drug delivery: Overcoming blood–brain barrier to treat neurodegenerative diseases

C Saraiva, C Praça, R Ferreira, T Santos… - Journal of controlled …, 2016 - Elsevier
The blood–brain barrier (BBB) is a vital boundary between neural tissue and circulating
blood. The BBB's unique and protective features control brain homeostasis as well as ion and …

[HTML][HTML] Nanocarriers as a powerful vehicle to overcome blood-brain barrier in treating neurodegenerative diseases: Focus on recent advances

X Niu, J Chen, J Gao - Asian journal of pharmaceutical sciences, 2019 - Elsevier
… The real cause of neurodegenerative disease is like a mystery and still … Neurodegenerative
disease including Alzheimer's disease(AD), Parkinson's disease(PD), Huntington disease(HD…

Treatment of neurodegenerative disorders through the blood–brain barrier using nanocarriers

N Poovaiah, Z Davoudi, H Peng, B Schlichtmann… - Nanoscale, 2018 - pubs.rsc.org
neurodegenerative diseases. There is a vast body of literature on the causes and treatments
of these neurodegenerative diseases. … Overall, nanotechnology can be used to overcome

The role of the blood brain barrier in neurodegenerative disorders and their treatment

AM Palmer - Journal of Alzheimer's Disease, 2011 - content.iospress.com
neurodegenerative diseases will have overtaken cancer to become the world’s second leading
cause of death, after cardiovascular disease… and colleagues has overcome this objection …

Overcoming the blood–brain barrier in neurodegenerative disorders and brain tumours

Z Ebrahimi, S Talaei, S Aghamiri… - IET …, 2020 - Wiley Online Library
… 1 a) can breathe new life into the treatment of neurodegenerative diseases like AD. As Figs.
1 b and c show, co-delivery of siRNAs with drugs by innovative multi-functional NPs could …

Overcoming the blood-brain barrier to taxane delivery for neurodegenerative diseases and brain tumors

A Rice, ML Michaelis, G Georg, Y Liu… - Journal of Molecular …, 2003 - Springer
… This study has focused on strategies to overcome P-gp-mediated efflux of Taxol analogs,
MT… , potentially, neurodegenerative diseases such as Alzheimer’s disease. However, taxol is a …

Neurodegenerative diseases–understanding their molecular bases and progress in the development of potential treatments

M Rowinska-Zyrek, M Salerno, H Kozlowski - Coordination Chemistry …, 2015 - Elsevier
… Another very important issue summarized in this review encompasses the strategies that
have been developed to overcome the blood–brain barrier (BBB) and deliver drugs inside the …

Nanotherapeutic strategies for the treatment of neurodegenerative diseases

M Huang, X Gu, X Gao - Brain targeted drug delivery system, 2019 - Elsevier
… of effective therapy for these neurodegenerative diseases. Firstly, their etiology … blood-brain
barrier (BBB). In this chapter, we will summarize the nanotherapeutic strategies to overcome

Neurodegenerative diseases and effective drug delivery: A review of challenges and novel therapeutics

A Akhtar, A Andleeb, TS Waris, M Bazzar… - Journal of Controlled …, 2021 - Elsevier
… Neurological diseases owing to the existence of the BBB and the bloodneurodegenerative
disorders. The regenerative medicine approaches are critically required to overcome disease

Recent advances with liposomes as drug carriers for treatment of neurodegenerative diseases

MW Seo, TE Park - Biomedical Engineering Letters, 2021 - Springer
… A major challenge in treating neurogenerative diseases is delivering drugs across the blood
Recent advances in liposome are providing alternatives to overcome BBB for more efficient …